about
sameAs
Aripiprazole for autism spectrum disorders (ASD)Aripiprazole for Autism Spectrum Disorders (ASD)Aripiprazole for autism spectrum disorders (ASD)Obesity in children with autism spectrum disorderRelaxation response-based yoga improves functioning in young children with autism: a pilot studyReward processing in autism: a thematic series.Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex.Prescription trends in children with pervasive developmental disorders: a claims data-based study in Japan.A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disordersMicronutrients versus standard medication management in autism: a naturalistic case-control studyEmerging drugs for the treatment of symptoms associated with autism spectrum disorders.The timing and specificity of prenatal immune risk factors for autism modeled in the mouse and relevance to schizophrenia.Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years.Obesity Prevention for Children with Developmental Disabilities.Autism: an emerging 'neuroimmune disorder' in search of therapy.Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia.Adenosine and autism: a spectrum of opportunities.Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher SurveyFocal brain inflammation and autism.Copy-number variations associated with autism spectrum disorder.An open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder.May the best friend be an enemy if not recognized early: possible role of omega-3 against cardiovascular abnormalities due to antipsychotics in the treatment of autism.Theoretical aspects of autism: causes--a review.Theoretical aspects of autism: biomarkers--a review.Aripiprazole: a review of its use in the treatment of irritability associated with autistic disorder patients aged 6-17.Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.Antipsychotics use in children and adolescents: An on-going challenge in clinical practice.Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.Medication prescribed by Australian paediatricians: Psychotropics predominate.Long-Term Aripiprazole in Youth With Developmental Disabilities Including AutismAn aberrant precision account of autism.Human Embryonic Stem Cells in the Treatment of Autism: A Case Series.Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders.Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study.Brief Report: Metformin for Antipsychotic-Induced Weight Gain in Youth with Autism Spectrum Disorder.Defining the hidden evidence in autism research. Forty per cent of rigorously designed clinical trials remain unpublished - a cross-sectional analysis.Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.Characteristics of Children Prescribed Antipsychotics: Analysis of Routinely Collected Data.Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program.Association of aggressive behaviours with psychiatric disorders, age, sex and degree of intellectual disability: a large-scale survey.
P2860
Q24197830-6030873A-F82E-4CA7-9DAA-FE7EF03DAC42Q24236239-99A1AAC4-2D6D-42D9-B24E-51D40427E911Q26471439-1175CA5D-D1AE-4A13-9FA9-1F2D0219722FQ26860363-BFF31882-7F90-4C45-89E8-F1A81ED9ACD8Q30408053-76413517-A01F-4FF9-B5C4-BBEF65EDDB32Q30462673-2C267A9E-E4DF-4709-BF98-A32829CBE1BCQ30531079-854AE564-0046-4C5E-91BC-4B0E6F108496Q31107239-C62AC1B9-128F-44DD-B027-4DFAB647AB4CQ33690844-5B8CCC42-9C9D-441F-8AB8-4507E8629D11Q33874958-C5FC047B-6E43-4893-A922-6B2CB6258DA7Q34073325-7ADC9103-4518-4A44-9EDF-EEEFC0DCC093Q34147502-6432AFFC-2EF9-4AC6-93BE-2A42A9FC4C30Q34597411-04AE5802-E7AF-49A9-B6C6-87E86CAE94FAQ34711543-50525AD4-CD9B-4E7E-9124-63F5728B27C9Q34994653-CF82532F-6DB7-4395-BAEF-4E18B9172899Q35390344-7F1C22E0-509F-483E-89E5-E347F47F7927Q36485460-6270BB1A-E122-4FBE-B9C7-334C6889303AQ36703079-67B1A102-83C7-42D3-B545-6D9967048CE6Q36766675-ACFF159A-CB68-49F5-AE0E-5080A4274444Q37235652-B2E2384E-6CB4-4E90-8297-A4FAC64BC56BQ37409074-0A21C1A0-3178-44D1-9730-0D7003A2243BQ37617083-7E3E390D-4B07-4828-AF4E-67C2560FC64DQ37836867-5AD0AB49-2DFD-47B9-A098-C2BA1C564E36Q37836872-A69191C8-E453-47D4-8D93-94EC6E3E6867Q38122151-E16E35DC-2BDE-4666-9558-CE98BD31CF38Q38191299-57AA8D92-750F-47A8-A56F-342CD2790965Q38217992-ABEDCFEE-1A50-41D6-B700-6E73DB455C71Q38268023-0A2A2635-948E-4634-B2B7-442C035A9977Q38700848-374B5ED0-9AB7-41BC-893C-EE7F444276F4Q38977828-3AD98A52-E8E2-43E2-862E-90A12050D761Q39852583-FF418196-F1A7-4EF1-B1F5-89EE010FD0CEQ40171550-F16D166E-EDA7-42DE-AF05-BD038F456979Q42283184-5ED4D0DF-471D-487B-B6C4-97A62D8D7FAEQ44569444-1EFC2399-4595-48D0-A112-8529BA8EB0D7Q47217653-F653667E-82A6-449B-B1DE-D60834C9D399Q47874564-D51BECC4-CDDF-47A6-8976-391F14FD0D54Q47949661-A133A59F-2110-4803-9F2B-C72C2FB3B23DQ50301160-5E94684C-64C7-4DAD-8602-BFDD63EFEBBBQ50309513-4613F00A-AF19-47A6-B236-07DE9A0438C5Q50311393-529DC173-02F1-4B6E-8EA9-21D21183D9E1
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Antipsychotics in the treatment of autism
@ast
Antipsychotics in the treatment of autism
@en
Antipsychotics in the treatment of autism
@en-gb
Antipsychotics in the treatment of autism
@nl
type
label
Antipsychotics in the treatment of autism
@ast
Antipsychotics in the treatment of autism
@en
Antipsychotics in the treatment of autism
@en-gb
Antipsychotics in the treatment of autism
@nl
prefLabel
Antipsychotics in the treatment of autism
@ast
Antipsychotics in the treatment of autism
@en
Antipsychotics in the treatment of autism
@en-gb
Antipsychotics in the treatment of autism
@nl
P2093
P2860
P356
P1476
Antipsychotics in the treatment of autism
@en
P2093
Craig A Erickson
Craig A. Erickson
David J Posey
David J. Posey
Kimberly A Stigler
Kimberly A. Stigler
P2860
P356
10.1172/JCI32483
P407
P577
2008-01-01T00:00:00Z
2008-01-02T00:00:00Z